event thumb

    La Quinta Inn & Suites

  • DATE

    6-7 March

About Event

This two-day virtual conference focuses on translational aspects of addiction research among chemists, biologists, and behavioral scientists. The diversity of participants and attendees at this meeting (undergraduate students to senior faculty, chemists to psychiatrists) provides a unique venue for networking among different disciplines and in so doing promotes new and innovative approaches to medications development in addictions biology. The meeting provides a stimulating environment for young scientists who are strongly encouraged to present their work and interact with senior scientists. The BBC meeting has served as a “launch pad” for many young, innovative investigators to join the ever-growing world of SUD research.

2010 Featured Speakers


Christian Heidbreder, PhD

Reckitt Benckiser Pharmaceuticals

Topic: Current perspectives on selective dopamine D3 receptor antagonists as pharmacotherapeutics for addictions and related disorders


R Adron Harris, PhD

University of Texas at Austin

Topic: Small molecule seeks protein partners for meaningful relationship


F Ivy Carroll, PhD

Research Triangle Institute

Topic: Development of selective kappa opioid receptor antagonists


Plenary Speakers


Amy H Newman, PhD

National Institute on Drug Abuse

Evolution of D3 receptor antagonists and partial agonists


Bruce Jenkins, PhD

Harvard Medical School/Massachusetts General Hospital

phMRI of D3 receptors in rodents and primates


Robert R Luedtke, PhD

University of North Texas Health Science Center

Functional selectivity of D3 dopamine receptor-selective ligands


Michael A Nader, PhD

Wake Forest University

Interactions of cocaine history with the behavioral effects of D3 compounds in nonhuman primates